Skip to content
SentinelMarket desk
Switch to dark mode

듀켐바이오

176750KOSDAQView the 제약 sectorTheme Bio & healthcare

9,480KRWMarket close of 10/21 (Wed)

Up +5.57%+500KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)8,420KRWDown -11.18%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
9,210
High
9,550
Low
9,010
Day range
Day range low 9,010 high 9,550, open 9,210, close 9,480, previous close 8,980
Volume
88×10K shares
8.1B KRW 2.13× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 5,440 to 11,680 won, 65% up from the low

65% of the way up from the lowest close in 1 year (252 sessions) · -18.8% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range+5.57%+5.57%, 1.0× the usual (20-session average ±5.31%)
    That day +5.57% · usual ±5.31% · large-move threshold ±10.6%

The other 3 are within the usual range

  • Trading value2.1×usual range
  • EarningsOperating income, 5 quartersOperating income, 5 quarters
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters)
  • Revenue9.7B KRWRevenue bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +14.7%
    vs. prior quarter
    -9.2%
  • Operating income1.3B KRWOperating income bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +87.5%
    vs. prior quarter
    -57.9%
  • Operating margin12.9%Operating margin bars for the last 5 quarters; the dark bar is this quarter
    vs. year ago
    +5.0 pp
    vs. prior quarter
    -15.0 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-05-14
2025Q1 669.78 million KRW2026Q1 1.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.